Merck Other Non-Current Liabilities 2010-2024 | MKKGY

Merck other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Merck other non-current liabilities for the quarter ending June 30, 2024 were $2.678B, a 1.2% decline year-over-year.
  • Merck other non-current liabilities for 2023 were $2.892B, a 8.58% increase from 2022.
  • Merck other non-current liabilities for 2022 were $2.664B, a 41.28% decline from 2021.
  • Merck other non-current liabilities for 2021 were $4.536B, a 8.14% decline from 2020.
Merck Annual Other Non-Current Liabilities
(Millions of US $)
2023 $2,892
2022 $2,664
2021 $4,536
2020 $4,938
2019 $4,013
2018 $3,741
2017 $3,842
2016 $3,968
2015 $3,662
2014 $4,291
2013 $2,560
2012 $2,717
2011 $8,281
2010 $
2009 $
Merck Quarterly Other Non-Current Liabilities
(Millions of US $)
2024-06-30 $2,678
2024-03-31 $2,825
2023-12-31 $2,892
2023-09-30 $2,451
2023-06-30 $2,711
2023-03-31 $2,652
2022-12-31 $2,664
2022-09-30 $2,487
2022-06-30 $2,281
2022-03-31 $3,774
2021-12-31 $4,536
2021-09-30 $4,475
2021-06-30 $4,629
2021-03-31 $4,598
2020-12-31 $4,938
2020-09-30 $16,222
2020-06-30 $4,320
2020-03-31 $3,802
2019-12-31 $4,013
2019-09-30 $4,929
2019-06-30 $4,316
2019-03-31 $4,068
2018-12-31 $3,741
2018-09-30 $3,459
2018-06-30 $3,758
2018-03-31 $3,924
2017-12-31 $3,842
2017-09-30 $4,004
2017-06-30 $3,687
2017-03-31 $3,740
2016-12-31 $3,968
2016-09-30 $4,435
2016-06-30 $4,280
2016-03-31 $3,970
2015-12-31 $3,662
2015-09-30 $3,550
2015-06-30 $3,357
2015-03-31 $4,107
2014-12-31 $4,291
2014-09-30 $2,612
2014-06-30 $3,028
2014-03-31 $2,895
2013-12-31 $2,560
2013-09-30 $2,978
2013-06-30 $3,012
2013-03-31 $3,001
2012-12-31 $2,717
2012-09-30 $6,885
2012-06-30 $7,943
2012-03-31
2011-12-31 $8,281
2011-09-30
2011-06-30 $9,591
2011-03-31
2010-12-31
2010-09-30 $9,323
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical MED-DRUGS $21.306B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
New York Community Bancorp (FLG) United States $4.269B 0.00
Acasti Pharma (GRCE) Canada $0.033B 0.00